| 2024 | The Association between Serum Lipid Levels and Tinnitus Prevalence and Severity in Korean Elderly: A Nationwide Population-Based Cross-Sectional Study
| YONSEI MEDICAL JOURNAL |
| 2024 | Antioxidant Efficacy of Hwangryunhaedok-tang through Nrf2 and AMPK Signaling Pathway against Neurological Disorders In Vivo and In Vitro
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
| 2024 | Assessment of Pharmacokinetic Effects of Herbal Medicines on Escitalopram
| THERAPEUTICS AND CLINICAL RISK MANAGEMENT |
| 2024 | Population pharmacokinetic-pharmacodynamic modeling of clopidogrel for dose regimen optimization based on CYP2C19 phenotypes: A proof of concept study
| CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY |
| 2023 | The efficacy and safety of low-molecular-weight collagen peptides for joint pain in patients with osteoarthritis: A randomized, double-blind, placebo-controlled study
| JOURNAL OF FUNCTIONAL FOODS |
| 2023 | Pharmacokinetic and pharmacodynamic interaction of DWP16001, a sodium-glucose cotransporter-2 inhibitor, with phentermine in healthy subjects | Expert Opinion on Drug Metabolism & Toxicology |
| 2023 | Pharmacokinetic and pharmacodynamic drug-drug interactions between evogliptin and empagliflozin or dapagliflozin in healthy male volunteers
| Clinical and Translational Science |
| 2023 | The effects of long-term cumulative HbA1c exposure on the development and onset time of dementia in the patients with type 2 diabetes mellitus: Hospital based retrospective study (2005-2021) | DIABETES RESEARCH AND CLINICAL PRACTICE |
| 2023 | Evaluation of pharmacokinetic interactions between lobeglitazone, empagliflozin, and metformin in healthy subjects
| Translational and Clinical Pharmacology |
| 2022 | Effect of Rifampicin on the Pharmacokinetics of Evogliptin in Healthy Volunteers
| DRUG DESIGN DEVELOPMENT AND THERAPY |
| 2022 | Effects of Hepatic Impairment on the Pharmacokinetic Profile and Safety of Lobeglitazone | CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT |
| 2021 | Comparison of the pharmacokinetics and pharmacodynamics of YH4808 in healthy subjects for defining an appropriate dosing regimen
| Translational and Clinical Pharmacology |
| 2021 | Pharmacokinetics and safety of evogliptin in hepatically impaired patients | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY |
| 2021 | Population Pharmacokinetics of Primaquine in the Korean Population
| PHARMACEUTICS |
| 2021 | Association Between 10-Year Fracture Probability and Nonalcoholic Fatty Liver Disease With or Without Sarcopenia in Korean Men: A Nationwide Population-Based Cross-Sectional Study
| FRONTIERS IN ENDOCRINOLOGY |
| 2020 | Efficacy of Lenvervimab, a Recombinant Human Immunoglobulin, in Treatment of Chronic Hepatitis B Virus Infection | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
| 2020 | Pharmacodynamic evaluation of YH4808 for Helicobacter pylori eradication in healthy subjects
| Translational and Clinical Pharmacology |
| 2020 | Association between daily sunlight exposure duration and diabetic retinopathy in Korean adults with diabetes: A nationwide population-based cross-sectional study
| PLOS ONE |
| 2020 | A Population Pharmacokinetic and Pharmacodynamic Model of CKD-519
| PHARMACEUTICS |
| 2020 | Evaluation of pharmacokinetic interactions between amoxicillin, clarithromycin, and the potassium-competitive acid blocker YH4808 in healthy subjects
| Translational and Clinical Pharmacology |
